Quick Answer
BLUE BIOFUELS, INC. reported Total Revenue of $60.0 thousand for fiscal year 2019.
BLUE BIOFUELS, INC. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | — | — | — | — | — | — |
| Revenue (ASC 606) | — | — | — | — | — | — |
| Net Income | -$2.87M -102.6% |
-$1.42M +53.6% |
-$3.06M +22.9% |
-$3.96M -85.1% |
-$2.14M +1.9% |
-$2.18M -317.0% |
| Diluted EPS | -$0.01 -80.0% |
-$0.01 +50.0% |
-$0.01 | — | — | — |
| Total Assets | $1.41M +1.3% |
$1.39M +34.9% |
$1.03M -6.8% |
$1.11M -39.8% |
$1.84M +106.0% |
$892.5K +46.4% |
| Cash and Equivalents | $65.2K +33.6% |
$48.8K +19.0% |
$41.0K -80.6% |
$211.9K -81.8% |
$1.16M +306.4% |
$286.6K +159.0% |
| Long-Term Debt | — | — | — | — | — | — |
| Stockholders Equity | -$3.71M -30.2% |
-$2.85M +20.1% |
-$3.56M -51.1% |
-$2.36M -68.8% |
-$1.40M +58.2% |
-$3.34M -0.1% |
| R&D Expense | $2.31M -1.0% |
$2.33M +25.9% |
$1.85M -21.3% |
$2.35M +113.0% |
$1.10M +44.6% |
$763.2K -4.3% |
| Operating Income | -$3.72M +8.4% |
-$4.06M -27.1% |
-$3.19M +18.9% |
-$3.93M -81.1% |
-$2.17M -9.1% |
-$1.99M -12.1% |
| Gross Profit | — | — | — | — | — | — |
| Shares Outstanding | 317.87M +3.2% |
307.96M +1.7% |
302.75M +4.4% |
289.94M +5.8% |
274.00M +13.4% |
241.72M +10.1% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Net Income | September 30, 2025 | -$422.5K | -122.6% | +54.1% |
| Diluted EPS | September 30, 2025 | -$0.00 | -116.7% | +66.7% |
| Total Assets | September 30, 2025 | $1.49M | -0.2% | +2.6% |
| Cash and Equivalents | September 30, 2025 | $95.2K | -36.3% | +1086.1% |
| Long-Term Debt | December 31, 2015 | $1.25M | +0.0% | +0.0% |
| Stockholders Equity | September 30, 2025 | -$3.06M | -21.7% | +3.6% |
| R&D Expense | September 30, 2025 | $485.7K | +18.2% | +3.0% |
| Operating Income | September 30, 2025 | -$836.3K | -29.1% | +7.4% |
| Shares Outstanding | September 30, 2025 | 314.72M | +3.0% | +0.9% |
- BLUE BIOFUELS, INC. reported Total Revenue of $60.0 thousand for fiscal year 2019.
- BLUE BIOFUELS, INC. showed a decrease of -55.3% in Total Revenue compared to the prior fiscal year.
- BLUE BIOFUELS, INC. reported Revenue (ASC 606) of $60.0 thousand for fiscal year 2019.
- BLUE BIOFUELS, INC. reported Net Income of -$2.87 million for fiscal year 2025.
- BLUE BIOFUELS, INC. showed a decrease of -102.6% in Net Income compared to the prior fiscal year.
- BLUE BIOFUELS, INC. reported Diluted EPS of $0.01 per share (loss) for fiscal year 2025.
- BLUE BIOFUELS, INC. showed a decrease of -80.0% in Diluted EPS compared to the prior fiscal year.
- BLUE BIOFUELS, INC. reported Total Assets of $1.41 million for fiscal year 2025.
- BLUE BIOFUELS, INC. showed an increase of +1.3% in Total Assets compared to the prior fiscal year.
- BLUE BIOFUELS, INC. reported Cash and Equivalents of $65.2 thousand for fiscal year 2025.
- BLUE BIOFUELS, INC. showed an increase of +33.6% in Cash and Equivalents compared to the prior fiscal year.
- BLUE BIOFUELS, INC. reported Long-Term Debt of $1.25 million for fiscal year 2015.
- BLUE BIOFUELS, INC. showed an increase of +0.0% in Long-Term Debt compared to the prior fiscal year.
- BLUE BIOFUELS, INC. reported Stockholders Equity of -$3.71 million for fiscal year 2025.
- BLUE BIOFUELS, INC. showed a decrease of -30.2% in Stockholders Equity compared to the prior fiscal year.
- BLUE BIOFUELS, INC. reported R&D Expense of $2.31 million for fiscal year 2025.
- BLUE BIOFUELS, INC. showed a decrease of -1.0% in R&D Expense compared to the prior fiscal year.
- BLUE BIOFUELS, INC. reported Operating Income of -$3.72 million for fiscal year 2025.
- BLUE BIOFUELS, INC. showed an increase of +8.4% in Operating Income compared to the prior fiscal year.
- BLUE BIOFUELS, INC. reported Gross Profit of $134.3 thousand for fiscal year 2017.
- BLUE BIOFUELS, INC. reported Shares Outstanding of 317.87 million shares for fiscal year 2025.
- BLUE BIOFUELS, INC. showed an increase of +3.2% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: